单位:[1]University, NO 2, East Yinghua Road, Chaoyang District, Beijing 100029, China[2]Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, NO 2, East Yinghua Road, Chaoyang District, Beijing 100029, China[3]Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, NO 2, East Yinghua Road, Chaoyang District, Beijing 100029, China[4]National Clinical Research Center for Respiratory Diseases, NO 2, East Yinghua Road, Chaoyang District, Beijing 100029, China[5]Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[6]Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China
Genetic risk factors are important for the occurrence and prognosis of venous thromboembolism (VTE). The studies of thrombophilia families are important for dissecting the genetic background of the thrombotic disease. We conducted the systematic review of all published family-based studies on VTE genetics across all racial groups through PubMed and Embase prior to 13th April 2020. This systematic review of 287 families (including 225 Caucasian families, 52 East Asian families, and families of other ethnicities) revealed a total of 21 different genes; the five most reported mutated genes wereF5(88/287, 30.7%),SERPINC1(67/287, 23.3%),PROC(65/287, 22.6%),F2(40/287, 13.9%) andPROS1(48/287, 16.7%). For Caucasian families,F5mutations were most frequently reported at 37.8% (85/225), whilePROS1mutations were most frequently reported, at 40.4% (21/52), for East Asian families (Chinese, Japanese and Korean). Factor V Leiden was reported more frequently in Caucasians than in East Asians. Missense mutations were reported frequently in theSERPINC1,PROCandPROS1genes. In conclusion, our study found the most likely mutated genes associated with VTE among different ethnic groups and provided indications for VTE genetic testing and research in the future.
基金:
Fund of The National Key Research and Development Program of China [2016YFC0905600]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [3332018184]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2018-I2M-1-003]
第一作者单位:[1]University, NO 2, East Yinghua Road, Chaoyang District, Beijing 100029, China[2]Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, NO 2, East Yinghua Road, Chaoyang District, Beijing 100029, China[3]Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, NO 2, East Yinghua Road, Chaoyang District, Beijing 100029, China[4]National Clinical Research Center for Respiratory Diseases, NO 2, East Yinghua Road, Chaoyang District, Beijing 100029, China
共同第一作者:
通讯作者:
通讯机构:[1]University, NO 2, East Yinghua Road, Chaoyang District, Beijing 100029, China[2]Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, NO 2, East Yinghua Road, Chaoyang District, Beijing 100029, China[3]Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, NO 2, East Yinghua Road, Chaoyang District, Beijing 100029, China[4]National Clinical Research Center for Respiratory Diseases, NO 2, East Yinghua Road, Chaoyang District, Beijing 100029, China[5]Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
推荐引用方式(GB/T 7714):
Zhang Yu,Zhang Zhu,Shu Shi,et al.The genetics of venous thromboembolism: a systematic review of thrombophilia families[J].JOURNAL of THROMBOSIS and THROMBOLYSIS.2021,51(2):359-369.doi:10.1007/s11239-020-02203-7.
APA:
Zhang Yu,Zhang Zhu,Shu Shi,Niu Wenquan,Xie Wanmu...&Wang Chen.(2021).The genetics of venous thromboembolism: a systematic review of thrombophilia families.JOURNAL of THROMBOSIS and THROMBOLYSIS,51,(2)
MLA:
Zhang Yu,et al."The genetics of venous thromboembolism: a systematic review of thrombophilia families".JOURNAL of THROMBOSIS and THROMBOLYSIS 51..2(2021):359-369